Ianthelliformisamine C (ditrifluoroacetate)
Ianthelliformisamine C ditrifluoroacetate is an antibiotic enhancer with activity against resistant Gram-negative bacteria. Ianthelliformisamine C ditrifluoroacetate has been shown to improve the efficacy of doxycycline against Pseudomonas aeruginosa. Ianthelliformisamine C ditrifluoroacetate was prepared using peptide coupling, resulting in high chemical yields of 27 to 91%. Ianthelliformisamine C ditrifluoroacetate exhibits its mechanism of action by inducing ATP efflux and causing membrane depolarization in bacterial cells.
Product Specifications
CAS Number
1643593-30-9
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/ianthelliformisamine-c-ditrifluoroacetate.html
Smiles
O=C(NCCCNCCCCNCCCNC(/C=C/C1=CC(Br)=C(OC)C(Br)=C1)=O)/C=C/C2=CC(Br)=C(OC)C(Br)=C2.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
Molecular Formula
C34H40Br4F6N4O8
Molecular Weight
1066.31
References & Citations
[1]New Ianthelliformisamine derivatives as antibiotic enhancers against resistant Gram-negative bacteria
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD106 / VCAM1 (B-K9), CF568 conjugate, 0.1mg/mL
TGF-beta (1D11.16.8), CF640R conjugate, 0.1mg/mL
CD31 / PECAM-1 (158-2B3), CF740 conjugate, 0.1mg/mL
CD106 / VCAM1 (B-K9), CF640R conjugate, 0.1mg/mL
